Shattuck Labs, Inc. Stock 12‑Month Price Target Cut to $14.86, Implies 108% UpsideTradingView·Aug 11 at 04:20 PMSTTK+3.86%
Analyst Reaffirms Buy on Shattuck Labs, Maintains $17 Price Target on TL1A Pipeline ProgressTip Ranks·Aug 11 at 01:45 PMSTTK+3.86%
HC Wainwright Cuts Shattuck Labs (NASDAQ:STTK) Price Target to $14.00Market Beat·Aug 11 at 11:42 AMSTTK+3.86%
Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseasesPUBT·Aug 11 at 06:33 AMSTTK+3.86%
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights | STTK Stock NewsStockTitan·Aug 10 at 09:15 PMSTTK+3.86%
This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Fridaybenzinga_article·Jul 24 at 08:29 AMSTTK+3.86%SUN+0.58%
Shattuck Labs (NASDAQ:STTK) Coverage Initiated by Analysts at JPMorgan Chase & Co.Market Beat·Jul 24 at 07:06 AMSTTK+3.86%
Shattuck Labs posts corporate presentation outlining DR3 antibody program for inflammatory diseasesPUBT·Jul 14 at 07:50 AMSTTK+3.86%
STTK: Lead DR3 antibody SL-325 shows promise for IBD with strong safety and low immunogenicityQuartr·Jul 14 at 07:45 AMSTTK+3.86%
Shattuck Labs CTO Abhinav A. Shukla sells 410 common shares worth $2,874.1PUBT·Jul 7 at 06:00 PMSTTK+3.86%
